Sec. 3. REPORT TO CONGRESS

394 words·~2 min read·/statute-compilations/comps-12007/sec-3

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 3 REPORT TO CONGRESS ###

(a)In General Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, the Administrator of the Substance Abuse and Mental Health Services Administration, the Director of the Agency for Healthcare Research and Quality, and the Director of the Centers for Disease Control and Prevention, in coordination with the Administrator of the Drug Enforcement Administration and in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall submit a report to the Committee on the Judiciary of the House of Representatives, the Committee on Energy and Commerce of the House of Representatives, the Committee on the Judiciary of the Senate, and the Committee on Health, Education, Labor, and Pensions of the Senate identifying— ####

(1)obstacles to legitimate patient access to controlled substances; ####

(2)issues with diversion of controlled substances; ####

(3)how collaboration between Federal, State, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances; ####

(4)the availability of medical education, training opportunities, and comprehensive clinical guidance for pain management and opioid prescribing, and any gaps that should be addressed; ####

(5)beneficial enhancements to State prescription drug monitoring programs, including enhancements to require comprehensive prescriber input and to expand access to the programs for appropriate authorized users; and ####

(6)steps to improve reporting requirements so that the public and Congress have more information regarding prescription opioids, such as the volume and formulation of prescription opioids prescribed annually, the dispensing of such prescription opioids, and outliers and trends within large data sets. ###

(b)Consultation The report under subsection

(a)shall incorporate feedback and recommendations from the following: ####

(1)Patient groups. ####

(2)Pharmacies. ####

(3)Drug manufacturers. ####

(4)Common or contract carriers and warehousemen. ####

(5)Hospitals, physicians, and other health care providers. ####

(6)State attorneys general. ####

(7)Federal, State, local, and tribal law enforcement agencies. ####

(8)Health insurance providers and entities that provide pharmacy benefit management services on behalf of a health insurance provider. ####

(9)Wholesale drug distributors. ####

(10)Veterinarians. ####

(11)Professional medical societies and boards. ####

(12)State and local public health authorities. ####

(13)Health services research organizations.